Colin J. Meyer
2016
In 2016, Colin J. Meyer earned a total compensation of $2.7M as Chief Medical Officer at REATA PHARMACEUTICALS, a 474% increase compared to previous year.
Compensation breakdown
| Bonus | $162,500 |
|---|---|
| Option Awards | $2,201,378 |
| Salary | $325,000 |
| Total | $2,688,878 |
Meyer received $2.2M in option awards, accounting for 82% of the total pay in 2016.
Meyer also received $162.5K in bonus and $325K in salary.
Rankings
In 2016, Colin J. Meyer's compensation ranked 3,630th out of 14,075 executives tracked by ExecPay. In other words, Meyer earned more than 74.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,630 out of 14,075 | 74th |
Division Manufacturing | 1,269 out of 5,486 | 77th |
Major group Chemicals And Allied Products | 392 out of 1,900 | 79th |
Industry group Drugs | 286 out of 1,543 | 82nd |
Industry Pharmaceutical Preparations | 225 out of 1,173 | 81st |
Source: SEC filing on April 24, 2017.
Meyer's colleagues
We found two more compensation records of executives who worked with Colin J. Meyer at REATA PHARMACEUTICALS in 2016.
News
REATA PHARMACEUTICALS CEO J Huff's 2021 pay falls 37% to $4M
April 29, 2022
REATA PHARMACEUTICALS CEO J Huff's 2020 pay rises 15% to $6.4M
April 30, 2021
REATA PHARMACEUTICALS CFO Manmeet Soni receives $13M in 2019
April 29, 2020
REATA PHARMACEUTICALS CEO J Huff's 2018 pay falls 82% to $935K
April 30, 2019